Phase 1 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Parkinson's Disease
Who may not be able to join:
- People who are unable to stand or walk without the help of a walking aid or assistive device
- People who experience symptoms while standing, such as dizziness, lightheadedness, low blood pressure on standing, severe leg or back pain, or medication side effects that would make safe participation difficult
- People with any other medical or psychiatric condition that could make safe participation in the study a concern (confirm with trial site)
- People with a history of heart or lung disease that causes symptoms
- People with a history of active rheumatoid arthritis
- People with a history of stroke or other neurological conditions that have left significant lasting problems with movement or sensation
- People with a history of severe ongoing pain requiring strong narcotic pain medications
- People with evidence of significant memory or thinking difficulties, based on a standard cognitive test score below 24 combined with notable difficulties managing daily activities
- People with venous leg ulcers or severely swollen leg veins
- Women who could potentially be pregnant, where a urine pregnancy test confirms pregnancy prior to a bone density scan procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chatkaew Pongmala, PhD, University of Michigan
Phone: 734-936-1174
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gait Speed; Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III; Montreal Cognitive Assessment; Timed Up and Go; 5 Times Sit to Stand
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.